Menu

Excited, but still have questions?

You might find the answers below. Or you might want to give us a call and stop by our office to discuss over coffee!

What do you mean by co-creation?

We collaborate with leading industry partners in the field of digital healthcare to identify problems that are worth solving. We then initiate a startup to solve these problems and create sustainable value linked to a functioning business model. After successfully entering the market and having established a sustainable business, the startup will be transferred to our partner. The co-creation enables our industry partners to take part in shaping the startup from the very beginning so that it aligns with their long-term strategic business goals. Hence, in a co-creation, we combine the speed and agility of the fast-paced startup world with the expertise of global corporate market leaders and share risks, investments and returns.

Who are your partners?

Our mission is to change digital healthcare and make people’s lives better. We collaborate with all major players in the healthcare sector, including pharmaceutical and medical device companies, nutrition manufacturers and retailers. In short, anyone who is willing to make digital healthcare happen.

How long do you need to build a startup?

It depends on the product, service and/or solution that the startup is offering. After a 5-day ideation sprint, we specify and verify our idea with a prototype-based field test during a 4 week “Buy-In” phase. In the following “Design” phase, we take an MVP to the market and perform a comprehensive due diligence on all critical business aspects of the startup, which takes another 2-3 months. Therefore, after 4-5 months, we have an MVP, initial market response and solid business plan with which to fuel the startup’s further development. Transition of the startup to our partner will then be made after 3-5 years.

How can my business already benefit from your startup before the exit?

We co-create the startup with you and fully customize it in line with your overall business development strategy. This is how we ensure to maximize the “spill-over effect” for your core business. Furthermore, part of our legal framework defines milestones. This not only guarantees a smooth transition during the exit phase but also allows you to benefit from as we grow our startup.

Do entrepreneurs have shares in their startup?

Yes. Our business model is designed to promote true entrepreneurship. Evoleeners participate directly in their startup and take full ownership from day one. Our entrepreneurs truly have their skin in the game, meaning that they are fully engaged and share both risk and reward.

On what startups are you currently working?

Currently, we have startups in the fields of cardiac monitoring, diabetes, dialysis and patient monitoring. And our pipeline is full of many ideas waiting to be realized.

Which startup will I be working on when I join Evoleen as entrepreneur?

As an Evoleener you only work on what you believe in. That’s why we make sure we hook you up with the startup that you find most interesting and promising. Also, as you will be closely working with other Evoleeners, we will introduce to you the rest of the team to find the best match.

Whose idea is it in the beginning?

We meet, we talk, we ideate. Once we identified a problem worth solving, Evoleen collects further insights using our own AI algorithms and entrepreneurs to dig deeper into the ecosystem of your focus area. We then propose a solution that targets your pain points and exceeds other offerings. Read more about our ideation tools.

Why are you successful?

The Evoleeners who participate in their startup are both experienced in the corporate world and entrepreneurs at heart. Above all, we only do what we believe in. And the ingredients of our secret sauce allow us to perform at a maximum rate and focus only what matters: creating value! Meet our superheroes.

Evoleen AG

Dreikönigstr. 34
8002 Zürich
Schweiz

hello@evoleen.com+41 44 552 52 11

By continuing to use our site you are agreeing to our cookie policy